Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
31,895,066
-
Share change
-
+1,087,606
-
Total reported value
-
$535,460,676
-
Put/Call ratio
-
80%
-
Price per share
-
$16.78
-
Number of holders
-
87
-
Value change
-
+$18,249,667
-
Number of buys
-
3
-
Number of sells
-
1
Institutional Holders of ANACOR PHARMACEUTICALS INC - COM (ANAC) as of Q4 2013
As of 31 Dec 2013,
ANACOR PHARMACEUTICALS INC - COM (ANAC) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,895,066 shares.
The largest 10 holders included
RHO CAPITAL PARTNERS INC, WELLINGTON MANAGEMENT CO LLP, BAKER BROS. ADVISORS LP, KINGDON CAPITAL MANAGEMENT, L.L.C., Palo Alto Investors, LLC, VHCP Management, LLC, Broadfin Capital, LLC, Lombard Odier Asset Management (USA) Corp, Consonance Capital Management LP, and QVT Financial LP.
This page lists
87
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.